Waligora Marcin, Różyńska Joanna, Piasecki Jan
Department of Philosophy and Bioethics, Faculty of Health Science, Jagiellonian University, Medical College, Michałowskiego 12, 31-126, Krakow, Poland.
Department of Ethics, Institute of Philosophy, University of Warsaw, Krakowskie Przedmieście 3, 00-927, Warsaw, Poland.
Med Health Care Philos. 2016 Mar;19(1):65-70. doi: 10.1007/s11019-015-9643-8.
A child's objection, refusal and dissent regarding participation in non-beneficial biomedical research must be respected, even when the parents or legal representatives have given their permission. There is, however, no consensus on the definition and criteria of a meaningful and valid child's objection. The aim of this article is to clarify this issue. In the first part we describe the problems of a child's assent in research. In the second part we distinguish and analyze two models of a child's objection to research: the capacity-based model and the distress-based model. In the last part we present arguments for a broader and unified understanding of a child's objection within regulations and practices. This will strengthen children's rights and facilitate the entire process of assessment of research protocols.
儿童对参与无益处的生物医学研究提出的异议、拒绝和不同意见必须得到尊重,即便父母或法定代表人已给予许可。然而,对于有意义且有效的儿童异议的定义和标准,目前尚无共识。本文旨在阐明这一问题。在第一部分,我们描述了儿童在研究中表示同意的相关问题。在第二部分,我们区分并分析了儿童对研究提出异议的两种模式:基于能力的模式和基于痛苦的模式。在最后一部分,我们提出论据,支持在法规和实践中对儿童异议形成更广泛和统一的理解。这将强化儿童权利,并促进研究方案评估的整个过程。